The interpretation of 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Carcinoma: New progress in radioactive iodine therapy of differentiated thyroid carcinoma
|更新时间:2025-12-31
|
The interpretation of 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Carcinoma: New progress in radioactive iodine therapy of differentiated thyroid carcinoma
林岩松, 李 娇. The interpretation of 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Carcinoma: New progress in radioactive iodine therapy of differentiated thyroid carcinoma[J]. China Oncology, 2016, 26(1): 1-12.
林岩松, 李 娇. The interpretation of 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Carcinoma: New progress in radioactive iodine therapy of differentiated thyroid carcinoma[J]. China Oncology, 2016, 26(1): 1-12. DOI: 10.3969/j.issn.1007-3969.2016.01.001.
The interpretation of 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Carcinoma: New progress in radioactive iodine therapy of differentiated thyroid carcinoma
the morbidity of differentiated thyroid carcinoma (DTC) has increased annually. American Thyroid Association (ATA) published the management guidelines for patients with thyroid nodules and DTC in 2006 in order to standardize their management. The ATA guidelines was updated for the first time in 2009 and its renewed version was completed in 2015 based on the considerable progress that had been made in the fields such as diagnostic assessment and management of thyroid nodules
surgery and radioactive iodine therapy for DTC in recent years. This article tried to interpret the updated contents about radioactive iodine therapy for DTC in 2015 version of the guidelines.
The interpretation of management guidelines for children with thyroid nodules and differentiated thyroid cancer: radioactive iodine therapy and new progress
Advances and controversies in the adjuvant treatment of early breast cancer
Important progress in surgical treatment of lung cancer in 2023
Progress of important clinical research of breast cancer in China in 2023
Important research progress in clinical practice for advanced breast cancer in 2023
Related Author
杨 珂
郑 容
林岩松
Lei FAN
Zhiqing WANG
Xiyu LIU
Bin QIAN
Haiquan CHEN
Related Institution
中国医学科学院肿瘤医院核医学科
中国医学科学院北京协和医学院北京协和医院核医学科
Department of Breast Surgery, Fudan University Shanghai Cancer Center; Fudan University Breast Cancer Institute; Department of Oncology, Shanghai Medical College, Fudan University
Institute of Thoracic Oncology, Fudan University
Department of Thoracic Surgery, Jiangdu People’s Hospital of Yangzhou City